Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach

[1]  A. G. Heidema,et al.  The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases , 2006, BMC Genetics.

[2]  Yongmei Liu,et al.  Genetics of progressive renal failure in diabetic kidney disease. , 2005, Kidney international. Supplement.

[3]  T. Mukherjee,et al.  The role of reactive oxygen species in TNFα-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells , 2005 .

[4]  V. Znojil,et al.  Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  S. Takasawa,et al.  Receptor for Advanced Glycation End Products Is a Promising Target of Diabetic Nephropathy , 2005, Annals of the New York Academy of Sciences.

[6]  S. Scherer,et al.  Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. , 2005, Diabetes.

[7]  P. Jacobsen.  Preventing end stage renal disease in diabetic patients — genetic aspect (part I) , 2005, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[8]  G. Wolf.  New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology , 2004, European journal of clinical investigation.

[9]  J. Tuomilehto,et al.  Population-based assessment of familial clustering of diabetic nephropathy in type 1 diabetes. , 2004, Diabetes.

[10]  S. Prabhakar.  Role of nitric oxide in diabetic nephropathy. , 2004, Seminars in nephrology.

[11]  Yan Shen,et al.  LDA - a java-based linkage disequilibrium analyzer , 2003, Bioinform..

[12]  T. Niu,et al.  Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. , 2003, Journal of the American Society of Nephrology : JASN.

[13]  H. Siragy,et al.  Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. , 2003, Kidney international.

[14]  J. Ott,et al.  Mathematical multi-locus approaches to localizing complex human trait genes , 2003, Nature Reviews Genetics.

[15]  J. Navarro,et al.  Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  R. Komers,et al.  Paradoxes of nitric oxide in the diabetic kidney. , 2003, American journal of physiology. Renal physiology.

[17]  Masafumi Koga,et al.  Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. , 2003, Metabolism: clinical and experimental.

[18]  N. Belyaev,et al.  Nitric oxide synthase gene polymorphisms and diabetic nephropathy , 2003, Diabetologia.

[19]  Dominic P. Kwiatkowski,et al.  In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading , 2003, Nature Genetics.

[20]  R. Hanson,et al.  Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. , 2002, Kidney international.

[21]  Hiroshi Sato,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2002, Nature Genetics.

[22]  K. Tokunaga,et al.  Association of eNOS Glu298Asp Polymorphism With End-Stage Renal Disease , 2002, Hypertension.

[23]  N. Yorioka,et al.  T-786→C Polymorphism of the Endothelial Nitric Oxide Synthase Gene Influences the Progression of Renal Disease , 2002, Nephron.

[24]  R. Hanson,et al.  Genetics of diabetic nephropathy in the pima indians , 2001, Current diabetes reports.

[25]  J. Ott,et al.  Trimming, weighting, and grouping SNPs in human case-control association studies. , 2001, Genome research.

[26]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[27]  S. Rich,et al.  Genetic analysis of nitric oxide and endothelin in end-stage renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  D. Moczulski,et al.  Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. , 2000, Kidney international.

[29]  R. Hanson,et al.  Segregation analysis of diabetic nephropathy in Pima Indians. , 2000, Diabetes.

[30]  S. Rich,et al.  Segregation analysis of urinary albumin excretion in families with type 2 diabetes. , 2000, Diabetes.

[31]  Gonçalo R. Abecasis,et al.  GOLD-Graphical Overview of Linkage Disequilibrium , 2000, Bioinform..

[32]  M. Cooper,et al.  Is there a role for endothelin antagonists in diabetic renal disease? , 2000, Diabetes, obesity & metabolism.

[33]  J. Gross,et al.  Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.

[34]  D. Moczulski,et al.  Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. , 1998, Diabetes.

[35]  R. Hanson,et al.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.

[36]  Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial , 1997, Diabetes.

[37]  G. Remuzzi,et al.  Endothelin: a mediator of renal disease progression. , 1997, Journal of nephrology.

[38]  O. B. O. T. I. Group,et al.  Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM , 1997, Diabetologia.

[39]  L. Tarnow,et al.  Genetics of diabetic nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.

[40]  A. Krolewski,et al.  Familial factors determine the development of diabetic nephropathy in patients with IDDM , 1996, Diabetologia.

[41]  N. Risch,et al.  A comparison of linkage disequilibrium measures for fine-scale mapping. , 1995, Genomics.

[42]  B. Freedman,et al.  Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  M. French,et al.  Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor‐alpha , 1993, Clinical and experimental immunology.

[44]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[45]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[46]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[47]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[48]  T. Mukherjee,et al.  The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. , 2005, Biochimica et biophysica acta.

[49]  D. Kohan.  Endothelins in the normal and diseased kidney. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[51]  J. Wetzels,et al.  The changing natural history of nephropathy in type I diabetes. , 1986, The American journal of medicine.